Chief of Staff - UCSD
Matthew Jenusaitis is Chief of Staff and Chief of Innovation and Transformation at the University of California San Diego Health System. Matthew oversees business development, new technology acquisition and implantation, regional hospital affiliations, and organizational efficiency improvements at the six UC San Diego Hospitals and four regional affiliates.
Prior to UC San Diego, Matthew was the President and CEO of OCTANe, an Orange County, CA non-profit organization focused on connecting people and ideas with capital and resources to fuel high technology innovation and economic development. OCTANe assisted more than 200 companies raise more than $500 Million in early stage capital building the high technology ecosystem in Southern California.
Matthew is an experienced health care professional with more than 25 years of engineering, sales and marketing, and executive level general management experience.
Matthew spent 15 years at Boston Scientific Corp., where he served in numerous presidential, general management, and executive marketing positions. His most recent position with Boston Scientific was as the president of the $600 Million Peripheral Interventions Division (formerly Medi-Tech) leading the acquisition and integration of Cryovascular Systems, Inc. and EndoTex, Inc..
Prior to Peripheral Interventions, Matthew led the integration of Interventional Technologies increasing their annual revenues from $25 Million in 2001 to more than $150 Million in 2003. Before that, he held executive marketing and marketing management positions in the Microvasive Endoscopy, Boston Scientific International, and Scimed Life Sciences divisions.
Matthew was also an executive in residence for the private equity firm Warburg Pincus, LLC. This led to Matthew assuming the role of President of ev3 Neurovasuclar, one of Warburg’s portfolio companies. During his career, Matthew also spent 8 years at Baxter Healthcare in both marketing and engineering management positions.
Matthew served on the board of directors of Creagh Medical in Galway, Ireland, a developer and manufacturer of specialty angioplasty balloons which sold to Surmodics for $32 Million in November 2015, and Pulsar Vascular in Santa Clara, CA, an early stage developer and manufacturer of neurovascular implants for the treatment of hemorrhagic stroke that sold to Johnson and Johnson in December 2016.
He sits on the advisory boards for Cornell’s School of Biomedical Engineering and Chapman University’s Schmid School of Science and Technology. He is also on the non-profit Board of Directors for Junior Achievement in Orange County, OC STEM, a 501c3 focused on the enhancement of STEM education in the school system, and Clean Tech OC, an organization focused on the economic enhancement of clean technology companies and the support of sustainable practices.
Jenusaitis holds a bachelor of science in chemical engineering cum laude from Cornell University, a master of science in bio-chemical engineering from Arizona State University and a master of business administration from University of California, Irvine. Matthew’s wife Lara is an assistant professor at the University of St. Augustine, and an assistant clinical professor of anatomy at the University of California, San Diego in both the medical and pharmacy schools. They live with their two daughters, Jada and Jenna, in Encinitas, California.